About
Stories
Businesses
Research
Therapies
Careers
Media
- Media Coverage
Contact
Events

In News

Home
News

glob image

glob image

Cadila Pharmaceuticals launches Cadalimab™ (Adalimumab biosimilar) for India

11th Sep, 2020 | News

Pharma Times

Pharma Times

PharmaBiz

PharmaBiz

Express Pharma

Express Pharma

Biosimilar Development

Biosimilar Development

Centre for Biosimilars

Centre for Biosimilars

About

Overview
Vision & Mission
Heritage
Values and Purpose
Board of Directors
Corporate Governance
CSR

Stories

Commitment Stories
Limitless Living
Healthcare
Innovation
People
Humanity

Businesses

APIs
Formulations
Contract Research Operation
Alliances
IRM Group Companies

Research

World’s First Innovation
R&D Chronicles
API Development
Formulation Development

Careers

Life at Cadila
Growth & Development
Join Us

Media

Press Releases
Events
Media Coverage

Therapies

Gastroenterology
Cardiology
Gynaecology
Diabetology
Oncology

Contact
ADR Reporting
Privacy Policy
Drug Counterfeiting

Corporate Identification No :
U24231GJ1991PLC015132

© 2024 Cadila Pharmaceuticals.
All rights reserved

Designed & Developed by Litmus

Array
(
)

To give you the best possible experience every time you visit our site, we use cookies to identify and store your preferences on your browser. Continuing to browse our site means that you are "ok" with this. Learn more about our privacy policy.

Okay